Medicine & TechnologyThe Antiviral, Remdesivir from Gilead Sciences, sparks hope as a new study revealed two-thirds of severely ill coronavirus patients improved after the use of the drug. Although the results of the study seem promising, many experts believe that proof of the drug's effectivity is still lacking. To answer important questions, more studies need to be conducted on a wide variety of patients. Click the link above to find out more.
New research suggests that coronavirus patients that live in areas in United States with higher levels of air pollution are more likely to die from the infection.
A 104-year-old refuses to go down from two different pandemics 100 years apart! The Spanish Flu and coronavirus survivor shows that age is just a number.
If you don't listen with your health officials about the danger of going out during this time of coronavirus pandemic, probably you'd heed to a bird's advice!